Jingtao Peng
- Topics
- Renal cell carcinoma treatment (5 papers)Ubiquitin and proteasome pathways (4 papers)Epigenetics and DNA Methylation (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jingtao Peng
16 papers receiving 314 citations
Peers
Comparison fields: 5 of 58
- Molecular Biology 228
- Cancer Research 112
- Oncology 60
- Pulmonary and Respiratory Medicine 56
- Surgery 37
Countries citing papers authored by Jingtao Peng
This map shows the geographic impact of Jingtao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingtao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingtao Peng more than expected).
Fields of papers citing papers by Jingtao Peng
This network shows the impact of papers produced by Jingtao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingtao Peng. The network helps show where Jingtao Peng may publish in the future.
Co-authorship network of co-authors of Jingtao Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Jingtao Peng. A scholar is included among the top collaborators of Jingtao Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingtao Peng. Jingtao Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 12 | |
| 3 | 11 | |
| 4 | BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma. | 12 |
| 5 | 0 | |
| 6 | 32 | |
| 7 | 12 | |
| 8 | 46 | |
| 9 | 30 | |
| 10 | 14 | |
| 11 | 1 | |
| 12 | 35 | |
| 13 | 37 | |
| 14 | 43 | |
| 15 | 13 | |
| 16 | 6 | |
| 17 | 5 |
About Jingtao Peng
Jingtao Peng is a scholar working on Transplantation, Cancer Research and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 314 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Ubiquitin and proteasome pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Transplantation (31 citations), Cancer Research (112 citations) and Molecular Biology (228 citations). Jingtao Peng has collaborated with scholars based in China and United States. Frequent co-authors include Jie Fan, Ren Mo, Jian Ma, Jiantao Xiao, Kun Gao, Chenji Wang, Pingzhao Zhang, Weiguo Li, Long Yu and Xiaofeng Jin. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.